According to The Nikkei Asia, NEC has developed an AI-powered system for analyzing colonoscopy images in real-time to support the detection of cancers and even hard-to-find polyps, as the company known for electronics enters the medical devices field.
New AI boasts over 90% accuracy in automatically detecting cancer and polyps thanks to NEC's mainstay facial recognition technology and is expected to provide robust support for physicians.
Some studies have shown that more than 20% of polyps are missed in current screenings.
The new system has been approved in Japan as a medical device, the first for NEC. The device will sell for roughly 4 million yen (US$ 38,400), with a sales target of 1,000 units in Japan and Europe over five years.
If you want to read this article in Japanese, please see the following link:
Subscribe to our English Newsletter